Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone vs Doubling ACE Inhibitor Dose in Diabetic Nephropathy
NCT00315016Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2007
- Primary completion
- Jul 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of eplerenone in diabetic nephropathy (DN), sponsored by Radboud University Medical Center. Started Jan 2007; status: completed.
02
Drugs
eplerenone
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00315016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00315016.